Related Experiment Video
Updated: Jan 24, 2026

MicroRNA Expression Profiles of Human iPS Cells, Retinal Pigment Epithelium Derived From iPS, and Fetal Retinal Pigment Epithelium
Published on: June 24, 2014
Expression of mutant mRNA and protein in pancreatic cells derived from MODY3- iPS cells
Shigeharu G Yabe1, Junko Nishida1, Satsuki Fukuda1
1Department of Regenerative Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Abstract:
Maturity-onset diabetes of the young (MODY) is a heterozygous monogenic diabetes; more than 14 disease genes have been identified. However, the pathogenesis of MODY is not fully understood because the patients' pancreatic beta cells are inaccessible. To elucidate the pathology of MODY, we established MODY3 patient-derived iPS (MODY3-iPS) cells using non-integrating Sendai virus (SeV) vector and examined the mutant mRNA and protein of HNF1A (Hepatocyte Nuclear factor 1A) after pancreatic lineage differentiation. Our patient had a cytosine insertion in the HNF1A gene (P291fsinsC) causing frameshift and making a premature termination codon (PTC). We confirmed these MODY3-iPS cells possessed the characteristics of pluripotent stem cells. After we differentiated them into pancreatic beta cells, transcripts of HNF1A gene were cloned and sequenced. We found that P291fsinsC mutant transcripts were much less frequent than wild ones, but they increased after adding cycloheximide (CHX) to the medium. These results suggested that mutant mRNA was destroyed by nonsense-mediated mRNA decay (NMD). Moreover, we were not able to detect any band of mutant proteins in pancreatic lineage cells which were differentiated from MODY3-iPSCs by western blot (WB) analysis. A scarcity of the truncated form of mutant protein may indicate that MODY3 might be caused by a haplo-insufficiency effect rather than a dominant negative manner.
Insights
Maturity-onset diabetes of the young (MODY) research used patient-derived stem cells to study HNF1A gene mutations. Findings suggest MODY3 may result from haplo-insufficiency, not dominant negative effects, due to mutant mRNA decay.
Area of Science:
- Genetics
- Endocrinology
- Stem Cell Biology
Background:
- Maturity-onset diabetes of the young (MODY) is a monogenic diabetes with over 14 identified genes.
- Understanding MODY pathogenesis is limited by the inaccessibility of patient pancreatic beta cells.
Purpose of the Study:
- To investigate the molecular pathology of MODY3 by examining HNF1A gene mutations in patient-derived induced pluripotent stem cells (iPSCs).
- To differentiate MODY3-iPSCs into pancreatic beta cells and analyze mutant HNF1A mRNA and protein expression.
Main Methods:
- Established MODY3 patient-derived iPSCs using a non-integrating Sendai virus (SeV) vector.
- Differentiated iPSCs into pancreatic lineage cells and analyzed HNF1A gene transcripts and proteins.
- Utilized cycloheximide (CHX) treatment and western blot (WB) analysis.
Main Results:
- MODY3-iPSCs exhibited pluripotency characteristics.
- Mutant HNF1A (P291fsinsC) transcripts were less frequent than wild-type but increased with CHX, suggesting nonsense-mediated mRNA decay (NMD).
- No mutant HNF1A protein bands were detected in differentiated pancreatic cells via WB.
Conclusions:
- The scarcity of mutant HNF1A protein suggests MODY3 pathogenesis is likely due to haplo-insufficiency rather than a dominant negative effect.
- Nonsense-mediated mRNA decay (NMD) plays a significant role in degrading mutant HNF1A transcripts in MODY3.
- Patient-derived iPSCs provide a valuable model for studying MODY pathogenesis.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Cell Specific Gene Expression
Somatic to iPS Cell Reprogramming

